IDEXX Laboratories Stock
IDEXX Laboratories, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Michael Erickson
- Employees
- 11,000
- Market cap
- $44.1 B
- IPO
- 21/06/1991
IDEXX Laboratories, Inc. is a global enterprise within the healthcare sector focused on creating, producing, and distributing a wide array of products and services. Established in 1983, the company is headquartered in Westbrook, USA. Its operations are organized into several key divisions, including the Companion…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
IDEXX Laboratories stock: price history
1D
+2.4%
1W
+8.2%
1M
+9.1%
6M
-4.9%
YTD
-17.2%
1Y
-12.1%
2Y
+20.8%
5Y
-11.8%
10Y
+404.4%
Next earnings date
Next earnings date
02/11/2026 (in 16 days)
Volatility around earnings
~17% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
IDEXX Laboratories stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about IDEXX Laboratories
Analyst assessment of IDEXX Laboratories
PRICE TARGET LOW
US$620.00
CONSENSUS
US$690.00
MEDIAN
US$710.00
PRICE TARGET HIGH
US$740.00
0
STRONG BUY
13
BUY
9
HOLD
1
SELL
0
STRONG SELL
23
TOTAL · Buy
As of: 16/10/2026
IDEXX Laboratories stock metrics
P/E
39.35
P/B
27.83
EV/EBITDA
27.85
RETURN ON EQUITY
21.0%
NET MARGIN
27.8%
DEBT/EQUITY
0.68
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.6%
FLOAT SHARES
78,482,520
AVG. DAILY VOLUME (30D)
521,166
Insider transactions (SEC)
Kingsley Lawrence D
Kingsley Lawrence D
Emerson Andrew
Emerson Andrew
HOOLEY JOSEPH L
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +2.4%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about IDEXX Laboratories stock
What does IDEXX Laboratories do?
IDEXX Laboratories, Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Michael Erickson, the company employs around 11,000 people.
The IPO was on 21/06/1991; the stock trades on NASDAQ under the ticker IDXX.
What do analysts say about IDEXX Laboratories stock?
23 analysts rate the stock, the consensus is Buy (as of 16/10/2026).
The average price target is US$690.00, ranging from US$620.00 to US$740.00, with a median of US$710.00.
This is an external assessment, not a statement by Market Jury.
When does IDEXX Laboratories report next?
The next earnings date is 02/11/2026.
Around past earnings, price swings were roughly 17% stronger than usual.
Does IDEXX Laboratories pay a dividend?
No, IDEXX Laboratories currently does not pay a dividend.
Which stocks are comparable to IDEXX Laboratories?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and Mettler-Toledo International.
How can I get IDEXX Laboratories stock analyzed?
Clicking "Analyze stock" lets five strategies assess IDEXX Laboratories against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.